Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report

The Maine issue with elder care

Aug 20, 2019

Latest Episodes

Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report

Can my DNA be patented? No, say justices

Nancy Marshall-Genzer Jun 13, 2013
Share Now on:
HTML EMBED:
COPY

The Supreme Court says human genes can’t be patented. But patents are allowed on synthetically-produced genetic material. The case involved Myriad Genetics, which holds patents on two genes that can determine whether a women has an increased chance of breast or ovarian cancer.

For companies that rely on patenting human genes to make products — like genetic tests for cancer — the court’s decision is disastrous.

“This is a major decision that’s kind of a tsunami that’s going to move through the biotech industry,” says Art Caplan, the director of ethics at NYU’s medical center.

Caplan says the tsunami will destroy companies that don’t innovate, that don’t pivot quickly and start making products with genes they’ve changed to make synthetic materials, which can be patented.

Juan Enriquez heads Excel Venture management, a biotech venture capital firm. He says lots of companies are already doing this, using synthetic material to make everything from food to biofuels.

He says, “You can design cells so they begin producing specific fuels or specific chemicals.” 

And now that human genes can’t be patented, researchers will have more access to them. It’ll be cheaper for patients to have their genetic codes mapped out. Edward Abrahams heads the Personalized Medicine Coalition and says your doctor could look at your genetic code to decide how much medicine, and which medicine, to give you.

He explains, “If you have a certain genetic profile, whether Drug A or B or C is going to work for you.”

Abrahams says the Supreme Court case did create winners and losers. But consumers should come out on the winning side.  With lots of new biotech products just over the horizon.

If you’re a member of your local public radio station, we thank you — because your support helps those stations keep programs like Marketplace on the air.  But for Marketplace to continue to grow, we need additional investment from those who care most about what we do: superfans like you.

Your donation — as little as $5 — helps us create more content that matters to you and your community, and to reach more people where they are – whether that’s radio, podcasts or online.

When you contribute directly to Marketplace, you become a partner in that mission: someone who understands that when we all get smarter, everybody wins.